News

A single case underscores the need for clinicians and hospitals to look beyond regulations when seeking consent.

“Consumer wearables fall between the cracks of what is already a fragmented and not particularly powerful set of government safeguards."

“The patients were the most interested in the technology. It essentially freed them.”

The researcher who helped shape HIPAA is now taking on gaps in patient data privacy nationwide.

Why a new debugger called DeepXplore could prepare artificial intelligence for the real world.

Why one expert is pushing to establish a fund to pay out victims.

“They’re only hypothetical in the sense that we haven’t had a catastrophic event yet. But we will.”

The administration is expected today to designate the opioid crisis a public health emergency. But what does that mean for patients’ data?

From 620,000 tweets, machine learning identified nearly 1,800 sales pitches for the deadly drugs.

Children’s Hospital of Philadelphia and the next-generation sequencing firm analyzed 1,000 genomes in under 3 hours.

But researchers must expand their focus beyond incidence rates.

Why the move could help physicians, healthcare organizations, and innovators.

Abbott's technology enables physicians to remotely identify arrhythmias in patients.

The agency continues to refine its device clearance process in accordance with the 21st Century Cures Act.

The start-up is building the first “big data collection of brainwave activity,” which aims to serve consumers and pharma.

“I think of it as a robotic revolution in rehabilitation.”

Although healthcare professionals created most of the videos analyzed in a new study, the content didn’t necessarily advance patient education.

A look at some of the successes and failures of state telehealth laws in 2017.

A University of Pennsylvania medical informatics expert describes how healthcare organizations can crunch the numbers to their advantage.

Researchers say the guidelines fill a void in many medical schools.

"If your app carefully sidesteps claiming any kind of medical intervention, then it's a health and wellness app and not a medical device -- and it is not regulated."

The island’s device manufacturers face major challenges, and consequences could extend across the country.

Researchers crunched the numbers from 602 New York City medical clinics and learned who’s not getting PrEP.

The company makes novel virtual reality technology for realistic surgery simulations.

What the FDA and manufacturers can do better when issuing future updates.

The "new era of personalized cancer therapy” is here: effective, novel, and expensive.

If health systems can buy in and enable patients to access their health records, the long-term benefits could be substantial.

Researchers want to help hospitals improve outcomes and cut costs.